1. Ma, Shijie, Liu, Jing-Yuan, Zhang, Jian-Ting. 2023. eIF3d: A driver of noncanonical cap-dependent translation of specific mRNAs and a trigger of biological/pathological processes. In The Journal of biological chemistry, 299, 104658. doi:10.1016/j.jbc.2023.104658. https://pubmed.ncbi.nlm.nih.gov/36997088/
2. Lamper, Adam M, Fleming, Rebecca H, Ladd, Kayla M, Lee, Amy S Y. . A phosphorylation-regulated eIF3d translation switch mediates cellular adaptation to metabolic stress. In Science (New York, N.Y.), 370, 853-856. doi:10.1126/science.abb0993. https://pubmed.ncbi.nlm.nih.gov/33184215/
3. Li, Chaobin, Lu, Kemei, Yang, Chenggang, Du, Wenfeng, Liang, Zhengkai. 2023. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1. In Journal of clinical laboratory analysis, 37, e24825. doi:10.1002/jcla.24825. https://pubmed.ncbi.nlm.nih.gov/36592991/
4. Li, Xia, Wang, Zhu, Liu, Guo, Guo, Jingjing. 2021. EIF3D promotes the progression of preeclampsia by inhibiting of MAPK/ERK1/2 pathway. In Reproductive toxicology (Elmsford, N.Y.), 105, 166-174. doi:10.1016/j.reprotox.2021.09.006. https://pubmed.ncbi.nlm.nih.gov/34520790/
5. Ishii, Satoko, Kakizuka, Taishi, Park, Sung-Joon, Nakai, Kenta, Miyanari, Yusuke. 2024. Genome-wide ATAC-see screening identifies TFDP1 as a modulator of global chromatin accessibility. In Nature genetics, 56, 473-482. doi:10.1038/s41588-024-01658-1. https://pubmed.ncbi.nlm.nih.gov/38361031/
6. Pan, Ying, Zhang, Zi-Ning, Yin, Lin-Bo, Jiang, Yong-Jun, Shang, Hong. 2019. Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function. In Journal of translational medicine, 17, 167. doi:10.1186/s12967-019-1925-0. https://pubmed.ncbi.nlm.nih.gov/31118081/